Join BOPA
Back to news articles

LAST FEW PLACES FOR THE BOPA NMP MASTERCLASS – FREE TO BOPA MEMBERS

By Rouge Media on 6th August 2019

Dear BOPA members,
 
There is less than a month to go for the next BOPA F2F NMP masterclass. Don’t delay and sign up NOW as slots are filling fast. Free for BOPA members!
 
We have an excellent program and have a whole afternoon with “The Method”( https://www.the-method.com/). The  Method offer an interactive exciting session to help you build on your patient consultation skills, this something not offered by any other study day.
 
Please see the link below to register for the “BOPA Masterclass – Non-Medical Prescribing” on Wednesday 4th September 2019.
 
https://www.eventbrite.co.uk/e/bopa-masterclass-non-medical-prescribing-tickets-62562305540
 
Kind Regards
 

Alkesh Patel
BOPA Education and Training Committee Chair
 
British Oncology Pharmacy Association 
www.bopa.org.uk
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article